News Archives

OptiKira Receives Significant Grant from ALS Association

CLEVELAND, OH – February 9, 2017 OptiKira has been awarded a $498,500 grant to support the development of their platform technology for the treatment of ALS (Lou Gehrig’s disease).  The company’s technology prevents progressive cell death and is...

Allinaire Therapeutics Receives Significant Funding

CLEVELAND, OH – January 26, 2017   Allinaire Therapeutics, a respiratory therapeutics start-up launched by BioMotiv, has recently received new investments from BioCrossroads’ Indiana Seed Fund and Indiana University’s Innovate Indiana Fund. The...

SapVax Launched to Develop Novel Cancer Vaccines Platform

CLEVELAND, OH – January 17, 2017 SapVax will develop a suite of first-in-class cancer vaccines based on a novel self-adjuvanting peptide platform technology for immuno-oncology applications.  It was formed by BioMotiv and UniServices, the commercialization...

Harrington Discovery Institute Announces 15 New Scholars

CLEVELAND, OH – January 16, 2017 The Harrington Discovery Institute (HDI) at University Hospitals in Cleveland, Ohio has announced 15 new recipients of the Harrington Scholar-Innovator and Partnership Awards. The Partnership Scholars were selected in...